Review




Structured Review

Data Sciences International ecg recordings
Ferroptosis inhibitors fail to rescue cardiac dysfunction. ( A ) Brief schedule of in vivo experiment. C57BL/6J mice were treated with ferrostatin-1 (Fer-1) or liproxstatin-1 (Lip-1) 24 h before doxorubicin injection and were dosed every 24 h. A single dose of doxorubicin was administered intraperitoneally once on day 1. Experimental groups: Vehicle, DOX (20 mg/kg, i.p.), DOX + Fer-1 (2 mg/kg, i.p.), and DOX + Lip-1 (10 mg/kg, i.p.) ( B ) The survival graph of mice from different groups was shown by Kaplan–Meier survival analysis. ( C ) Three days after intraperitoneal injection of doxorubicin, the mouse cardiac function was analyzed with <t>echocardiography.</t> The echocardiography data showed decreased fractional shortening and ejection fraction in mice treated with doxorubicin and Fer-1 or Lip-1. Survival rate, n = 5 per group; <t>ECG,</t> n = 5 per group. ( D ) Bar graph representation of the heart weight to body weight ratio of mice. ( E ) 3,3’-Diaminobenzidine immunohistochemical staining for 4-hydroxynonenal (4-HNE) in the mouse heart tissue; scale bars, 200 µm (left panel). Quantification of 4-HNE-specific 3,3’-Diaminobenzidine staining (right panel). ( F ) Bar graph representation of the N-terminal pro B-type natriuretic peptide (NT-proBNP) of mice. ( G ) Masson’s trichrome and Sirius red staining of fibrosis in the mouse heart (left panel) and quantification (right panel). ( H ) Western blot of ferroptosis cell death markers in mouse heart tissues treated with doxorubicin and Fer-1 or Lip-1. heart weight to body weight, n = 3 per group; 4-HNE, n = 3 per group; NT-proBNP, n = 7 per group; Masson’s trichrome and Sirius red, n = 3 per group; Western blots, n = 3 per group. Data are presented as mean ± S.D., where n represents the number of individual mice per group. Statistical significance was determined by one-way ANOVA followed by Sidak’s multiple comparison test for panels ( C , F ), and the Kruskal–Wallis test was used for panels ( D , E , G ), ns, no significance, * p < 0.05, ** p < 0.01, *** p < 0.005, **** p < 0.001.
Ecg Recordings, supplied by Data Sciences International, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ecg recordings/product/Data Sciences International
Average 86 stars, based on 1 article reviews
ecg recordings - by Bioz Stars, 2026-06
86/100 stars

Images

1) Product Images from "Limitations of Ferroptosis Inhibitors on the Doxorubicin-Induced Cardiotoxicity"

Article Title: Limitations of Ferroptosis Inhibitors on the Doxorubicin-Induced Cardiotoxicity

Journal: Antioxidants

doi: 10.3390/antiox15010027

Ferroptosis inhibitors fail to rescue cardiac dysfunction. ( A ) Brief schedule of in vivo experiment. C57BL/6J mice were treated with ferrostatin-1 (Fer-1) or liproxstatin-1 (Lip-1) 24 h before doxorubicin injection and were dosed every 24 h. A single dose of doxorubicin was administered intraperitoneally once on day 1. Experimental groups: Vehicle, DOX (20 mg/kg, i.p.), DOX + Fer-1 (2 mg/kg, i.p.), and DOX + Lip-1 (10 mg/kg, i.p.) ( B ) The survival graph of mice from different groups was shown by Kaplan–Meier survival analysis. ( C ) Three days after intraperitoneal injection of doxorubicin, the mouse cardiac function was analyzed with echocardiography. The echocardiography data showed decreased fractional shortening and ejection fraction in mice treated with doxorubicin and Fer-1 or Lip-1. Survival rate, n = 5 per group; ECG, n = 5 per group. ( D ) Bar graph representation of the heart weight to body weight ratio of mice. ( E ) 3,3’-Diaminobenzidine immunohistochemical staining for 4-hydroxynonenal (4-HNE) in the mouse heart tissue; scale bars, 200 µm (left panel). Quantification of 4-HNE-specific 3,3’-Diaminobenzidine staining (right panel). ( F ) Bar graph representation of the N-terminal pro B-type natriuretic peptide (NT-proBNP) of mice. ( G ) Masson’s trichrome and Sirius red staining of fibrosis in the mouse heart (left panel) and quantification (right panel). ( H ) Western blot of ferroptosis cell death markers in mouse heart tissues treated with doxorubicin and Fer-1 or Lip-1. heart weight to body weight, n = 3 per group; 4-HNE, n = 3 per group; NT-proBNP, n = 7 per group; Masson’s trichrome and Sirius red, n = 3 per group; Western blots, n = 3 per group. Data are presented as mean ± S.D., where n represents the number of individual mice per group. Statistical significance was determined by one-way ANOVA followed by Sidak’s multiple comparison test for panels ( C , F ), and the Kruskal–Wallis test was used for panels ( D , E , G ), ns, no significance, * p < 0.05, ** p < 0.01, *** p < 0.005, **** p < 0.001.
Figure Legend Snippet: Ferroptosis inhibitors fail to rescue cardiac dysfunction. ( A ) Brief schedule of in vivo experiment. C57BL/6J mice were treated with ferrostatin-1 (Fer-1) or liproxstatin-1 (Lip-1) 24 h before doxorubicin injection and were dosed every 24 h. A single dose of doxorubicin was administered intraperitoneally once on day 1. Experimental groups: Vehicle, DOX (20 mg/kg, i.p.), DOX + Fer-1 (2 mg/kg, i.p.), and DOX + Lip-1 (10 mg/kg, i.p.) ( B ) The survival graph of mice from different groups was shown by Kaplan–Meier survival analysis. ( C ) Three days after intraperitoneal injection of doxorubicin, the mouse cardiac function was analyzed with echocardiography. The echocardiography data showed decreased fractional shortening and ejection fraction in mice treated with doxorubicin and Fer-1 or Lip-1. Survival rate, n = 5 per group; ECG, n = 5 per group. ( D ) Bar graph representation of the heart weight to body weight ratio of mice. ( E ) 3,3’-Diaminobenzidine immunohistochemical staining for 4-hydroxynonenal (4-HNE) in the mouse heart tissue; scale bars, 200 µm (left panel). Quantification of 4-HNE-specific 3,3’-Diaminobenzidine staining (right panel). ( F ) Bar graph representation of the N-terminal pro B-type natriuretic peptide (NT-proBNP) of mice. ( G ) Masson’s trichrome and Sirius red staining of fibrosis in the mouse heart (left panel) and quantification (right panel). ( H ) Western blot of ferroptosis cell death markers in mouse heart tissues treated with doxorubicin and Fer-1 or Lip-1. heart weight to body weight, n = 3 per group; 4-HNE, n = 3 per group; NT-proBNP, n = 7 per group; Masson’s trichrome and Sirius red, n = 3 per group; Western blots, n = 3 per group. Data are presented as mean ± S.D., where n represents the number of individual mice per group. Statistical significance was determined by one-way ANOVA followed by Sidak’s multiple comparison test for panels ( C , F ), and the Kruskal–Wallis test was used for panels ( D , E , G ), ns, no significance, * p < 0.05, ** p < 0.01, *** p < 0.005, **** p < 0.001.

Techniques Used: In Vivo, Injection, Immunohistochemical staining, Staining, Western Blot, Comparison

Ferroptosis inhibitors do not alleviate doxorubicin-induced arrhythmic changes in mice. ( A ) Electrocardiogram (ECG) traces recorded on day 1 after DOX administration with or without ferroptosis inhibitors, showing various arrhythmic events, including tachyarrhythmia, frequent premature ventricular contractions, irregular rhythm, and cardiac arrest. Red arrows indicate representative arrhythmic events, including premature ventricular contractions and irregular R−R intervals. ( B ) ECG traces recorded on day 21, demonstrating the progression of arrhythmic changes, including atrioventricular (AV) block and bradycardia with AV block, indicated by red arrows. n = 4 per group. Data are presented as mean ± S.D., where n represents the number of individual mice per group. Statistical significance was determined by one-way ANOVA followed by Sidak’s multiple comparison test.
Figure Legend Snippet: Ferroptosis inhibitors do not alleviate doxorubicin-induced arrhythmic changes in mice. ( A ) Electrocardiogram (ECG) traces recorded on day 1 after DOX administration with or without ferroptosis inhibitors, showing various arrhythmic events, including tachyarrhythmia, frequent premature ventricular contractions, irregular rhythm, and cardiac arrest. Red arrows indicate representative arrhythmic events, including premature ventricular contractions and irregular R−R intervals. ( B ) ECG traces recorded on day 21, demonstrating the progression of arrhythmic changes, including atrioventricular (AV) block and bradycardia with AV block, indicated by red arrows. n = 4 per group. Data are presented as mean ± S.D., where n represents the number of individual mice per group. Statistical significance was determined by one-way ANOVA followed by Sidak’s multiple comparison test.

Techniques Used: Blocking Assay, Comparison



Similar Products

96
ADInstruments lead ecg recordings
Lead Ecg Recordings, supplied by ADInstruments, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lead ecg recordings/product/ADInstruments
Average 96 stars, based on 1 article reviews
lead ecg recordings - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier

86
Mouse Specifics noninvasive ecg recording platform
Noninvasive Ecg Recording Platform, supplied by Mouse Specifics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/noninvasive ecg recording platform/product/Mouse Specifics
Average 86 stars, based on 1 article reviews
noninvasive ecg recording platform - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Technology Development Co single channel mi rhythm holter ecg recorder
Schematic overview of the proposed pilot fatigue detection framework. The pipeline consists of three sequential stages: (1) Signal preprocessing and segmentation of <t>EEG/ECG</t> data, (2) Pivotal feature selection using ANOVA and EEG channel selection using SVM-based AUC ranking, and (3) Final fatigue classification using the XGBoost model. With permission from .
Single Channel Mi Rhythm Holter Ecg Recorder, supplied by Technology Development Co, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/single channel mi rhythm holter ecg recorder/product/Technology Development Co
Average 86 stars, based on 1 article reviews
single channel mi rhythm holter ecg recorder - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Data Sciences International ecg recordings
Ferroptosis inhibitors fail to rescue cardiac dysfunction. ( A ) Brief schedule of in vivo experiment. C57BL/6J mice were treated with ferrostatin-1 (Fer-1) or liproxstatin-1 (Lip-1) 24 h before doxorubicin injection and were dosed every 24 h. A single dose of doxorubicin was administered intraperitoneally once on day 1. Experimental groups: Vehicle, DOX (20 mg/kg, i.p.), DOX + Fer-1 (2 mg/kg, i.p.), and DOX + Lip-1 (10 mg/kg, i.p.) ( B ) The survival graph of mice from different groups was shown by Kaplan–Meier survival analysis. ( C ) Three days after intraperitoneal injection of doxorubicin, the mouse cardiac function was analyzed with <t>echocardiography.</t> The echocardiography data showed decreased fractional shortening and ejection fraction in mice treated with doxorubicin and Fer-1 or Lip-1. Survival rate, n = 5 per group; <t>ECG,</t> n = 5 per group. ( D ) Bar graph representation of the heart weight to body weight ratio of mice. ( E ) 3,3’-Diaminobenzidine immunohistochemical staining for 4-hydroxynonenal (4-HNE) in the mouse heart tissue; scale bars, 200 µm (left panel). Quantification of 4-HNE-specific 3,3’-Diaminobenzidine staining (right panel). ( F ) Bar graph representation of the N-terminal pro B-type natriuretic peptide (NT-proBNP) of mice. ( G ) Masson’s trichrome and Sirius red staining of fibrosis in the mouse heart (left panel) and quantification (right panel). ( H ) Western blot of ferroptosis cell death markers in mouse heart tissues treated with doxorubicin and Fer-1 or Lip-1. heart weight to body weight, n = 3 per group; 4-HNE, n = 3 per group; NT-proBNP, n = 7 per group; Masson’s trichrome and Sirius red, n = 3 per group; Western blots, n = 3 per group. Data are presented as mean ± S.D., where n represents the number of individual mice per group. Statistical significance was determined by one-way ANOVA followed by Sidak’s multiple comparison test for panels ( C , F ), and the Kruskal–Wallis test was used for panels ( D , E , G ), ns, no significance, * p < 0.05, ** p < 0.01, *** p < 0.005, **** p < 0.001.
Ecg Recordings, supplied by Data Sciences International, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ecg recordings/product/Data Sciences International
Average 86 stars, based on 1 article reviews
ecg recordings - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Micromed Inc 12 lead electrocardiography recorder
Ferroptosis inhibitors fail to rescue cardiac dysfunction. ( A ) Brief schedule of in vivo experiment. C57BL/6J mice were treated with ferrostatin-1 (Fer-1) or liproxstatin-1 (Lip-1) 24 h before doxorubicin injection and were dosed every 24 h. A single dose of doxorubicin was administered intraperitoneally once on day 1. Experimental groups: Vehicle, DOX (20 mg/kg, i.p.), DOX + Fer-1 (2 mg/kg, i.p.), and DOX + Lip-1 (10 mg/kg, i.p.) ( B ) The survival graph of mice from different groups was shown by Kaplan–Meier survival analysis. ( C ) Three days after intraperitoneal injection of doxorubicin, the mouse cardiac function was analyzed with <t>echocardiography.</t> The echocardiography data showed decreased fractional shortening and ejection fraction in mice treated with doxorubicin and Fer-1 or Lip-1. Survival rate, n = 5 per group; <t>ECG,</t> n = 5 per group. ( D ) Bar graph representation of the heart weight to body weight ratio of mice. ( E ) 3,3’-Diaminobenzidine immunohistochemical staining for 4-hydroxynonenal (4-HNE) in the mouse heart tissue; scale bars, 200 µm (left panel). Quantification of 4-HNE-specific 3,3’-Diaminobenzidine staining (right panel). ( F ) Bar graph representation of the N-terminal pro B-type natriuretic peptide (NT-proBNP) of mice. ( G ) Masson’s trichrome and Sirius red staining of fibrosis in the mouse heart (left panel) and quantification (right panel). ( H ) Western blot of ferroptosis cell death markers in mouse heart tissues treated with doxorubicin and Fer-1 or Lip-1. heart weight to body weight, n = 3 per group; 4-HNE, n = 3 per group; NT-proBNP, n = 7 per group; Masson’s trichrome and Sirius red, n = 3 per group; Western blots, n = 3 per group. Data are presented as mean ± S.D., where n represents the number of individual mice per group. Statistical significance was determined by one-way ANOVA followed by Sidak’s multiple comparison test for panels ( C , F ), and the Kruskal–Wallis test was used for panels ( D , E , G ), ns, no significance, * p < 0.05, ** p < 0.01, *** p < 0.005, **** p < 0.001.
12 Lead Electrocardiography Recorder, supplied by Micromed Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/12 lead electrocardiography recorder/product/Micromed Inc
Average 86 stars, based on 1 article reviews
12 lead electrocardiography recorder - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Fukuda Denshi Co digital ecg recorder
Ferroptosis inhibitors fail to rescue cardiac dysfunction. ( A ) Brief schedule of in vivo experiment. C57BL/6J mice were treated with ferrostatin-1 (Fer-1) or liproxstatin-1 (Lip-1) 24 h before doxorubicin injection and were dosed every 24 h. A single dose of doxorubicin was administered intraperitoneally once on day 1. Experimental groups: Vehicle, DOX (20 mg/kg, i.p.), DOX + Fer-1 (2 mg/kg, i.p.), and DOX + Lip-1 (10 mg/kg, i.p.) ( B ) The survival graph of mice from different groups was shown by Kaplan–Meier survival analysis. ( C ) Three days after intraperitoneal injection of doxorubicin, the mouse cardiac function was analyzed with <t>echocardiography.</t> The echocardiography data showed decreased fractional shortening and ejection fraction in mice treated with doxorubicin and Fer-1 or Lip-1. Survival rate, n = 5 per group; <t>ECG,</t> n = 5 per group. ( D ) Bar graph representation of the heart weight to body weight ratio of mice. ( E ) 3,3’-Diaminobenzidine immunohistochemical staining for 4-hydroxynonenal (4-HNE) in the mouse heart tissue; scale bars, 200 µm (left panel). Quantification of 4-HNE-specific 3,3’-Diaminobenzidine staining (right panel). ( F ) Bar graph representation of the N-terminal pro B-type natriuretic peptide (NT-proBNP) of mice. ( G ) Masson’s trichrome and Sirius red staining of fibrosis in the mouse heart (left panel) and quantification (right panel). ( H ) Western blot of ferroptosis cell death markers in mouse heart tissues treated with doxorubicin and Fer-1 or Lip-1. heart weight to body weight, n = 3 per group; 4-HNE, n = 3 per group; NT-proBNP, n = 7 per group; Masson’s trichrome and Sirius red, n = 3 per group; Western blots, n = 3 per group. Data are presented as mean ± S.D., where n represents the number of individual mice per group. Statistical significance was determined by one-way ANOVA followed by Sidak’s multiple comparison test for panels ( C , F ), and the Kruskal–Wallis test was used for panels ( D , E , G ), ns, no significance, * p < 0.05, ** p < 0.01, *** p < 0.005, **** p < 0.001.
Digital Ecg Recorder, supplied by Fukuda Denshi Co, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/digital ecg recorder/product/Fukuda Denshi Co
Average 86 stars, based on 1 article reviews
digital ecg recorder - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Fukuda Denshi Co ecg recorder cardimax fx 2111
<t>ECG</t> changes and cardiac enzymes changes in the different studied groups: a: significance from the control group by LSD at p ≤ 0.05. b: Significance from the hypothyroid group by LSD at p ≤ 0.05. c: Significance from the L-thyroxine-treated hypothyroid group by LSD at p ≤ 0.05. d: Significance from the sesame oil-treated hypothyroid group by LSD at p ≤ 0.05.
Ecg Recorder Cardimax Fx 2111, supplied by Fukuda Denshi Co, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ecg recorder cardimax fx 2111/product/Fukuda Denshi Co
Average 86 stars, based on 1 article reviews
ecg recorder cardimax fx 2111 - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Abbott Laboratories multiple electrocardiogram recording patches
<t>ECG</t> changes and cardiac enzymes changes in the different studied groups: a: significance from the control group by LSD at p ≤ 0.05. b: Significance from the hypothyroid group by LSD at p ≤ 0.05. c: Significance from the L-thyroxine-treated hypothyroid group by LSD at p ≤ 0.05. d: Significance from the sesame oil-treated hypothyroid group by LSD at p ≤ 0.05.
Multiple Electrocardiogram Recording Patches, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/multiple electrocardiogram recording patches/product/Abbott Laboratories
Average 86 stars, based on 1 article reviews
multiple electrocardiogram recording patches - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

Image Search Results


Schematic overview of the proposed pilot fatigue detection framework. The pipeline consists of three sequential stages: (1) Signal preprocessing and segmentation of EEG/ECG data, (2) Pivotal feature selection using ANOVA and EEG channel selection using SVM-based AUC ranking, and (3) Final fatigue classification using the XGBoost model. With permission from .

Journal: Frontiers in Human Neuroscience

Article Title: To assure aviation safety: the pilot fatigue detection based on short-term multimodal physiological signals

doi: 10.3389/fnhum.2026.1743936

Figure Lengend Snippet: Schematic overview of the proposed pilot fatigue detection framework. The pipeline consists of three sequential stages: (1) Signal preprocessing and segmentation of EEG/ECG data, (2) Pivotal feature selection using ANOVA and EEG channel selection using SVM-based AUC ranking, and (3) Final fatigue classification using the XGBoost model. With permission from .

Article Snippet: Pilot ECG signals were collected using a single-channel Mi-Rhythm Holter ECG recorder (Shenzhen Ruikang Hongye Technology Development Co., Ltd., China) at a sampling rate of 250 Hz.

Techniques: Selection

Illustration of the ECG device. The single-channel Mi-Rhythm Holter recorder includes (a) the host unit, (b) a protective silicone sleeve, and (c) disposable electrode patches. This compact design allows for unobtrusive recording of cardiac activity.

Journal: Frontiers in Human Neuroscience

Article Title: To assure aviation safety: the pilot fatigue detection based on short-term multimodal physiological signals

doi: 10.3389/fnhum.2026.1743936

Figure Lengend Snippet: Illustration of the ECG device. The single-channel Mi-Rhythm Holter recorder includes (a) the host unit, (b) a protective silicone sleeve, and (c) disposable electrode patches. This compact design allows for unobtrusive recording of cardiac activity.

Article Snippet: Pilot ECG signals were collected using a single-channel Mi-Rhythm Holter ECG recorder (Shenzhen Ruikang Hongye Technology Development Co., Ltd., China) at a sampling rate of 250 Hz.

Techniques: Activity Assay

Visualization of the EEG and ECG signal preprocessing and segmentation. Both EEG and ECG signals are filtered (0.5–30 Hz) and segmented into 2-s epochs with a 50% overlap using a sliding window technique. This synchronized segmentation ensures that each data sample contains aligned multimodal information.

Journal: Frontiers in Human Neuroscience

Article Title: To assure aviation safety: the pilot fatigue detection based on short-term multimodal physiological signals

doi: 10.3389/fnhum.2026.1743936

Figure Lengend Snippet: Visualization of the EEG and ECG signal preprocessing and segmentation. Both EEG and ECG signals are filtered (0.5–30 Hz) and segmented into 2-s epochs with a 50% overlap using a sliding window technique. This synchronized segmentation ensures that each data sample contains aligned multimodal information.

Article Snippet: Pilot ECG signals were collected using a single-channel Mi-Rhythm Holter ECG recorder (Shenzhen Ruikang Hongye Technology Development Co., Ltd., China) at a sampling rate of 250 Hz.

Techniques:

Comparison of single-channel SVM classification performance (AUC) utilizing features from single vs. fused frequency bands. The bar chart compares the AUC of single-channel SVM classifiers using features from individual frequency bands versus fused features from all 4 bands (red bars). Data are obtained based on 10-fold cross-clip cross-validation. Adapted with permission from .

Journal: Frontiers in Human Neuroscience

Article Title: To assure aviation safety: the pilot fatigue detection based on short-term multimodal physiological signals

doi: 10.3389/fnhum.2026.1743936

Figure Lengend Snippet: Comparison of single-channel SVM classification performance (AUC) utilizing features from single vs. fused frequency bands. The bar chart compares the AUC of single-channel SVM classifiers using features from individual frequency bands versus fused features from all 4 bands (red bars). Data are obtained based on 10-fold cross-clip cross-validation. Adapted with permission from .

Article Snippet: Pilot ECG signals were collected using a single-channel Mi-Rhythm Holter ECG recorder (Shenzhen Ruikang Hongye Technology Development Co., Ltd., China) at a sampling rate of 250 Hz.

Techniques: Comparison, Biomarker Discovery

Ferroptosis inhibitors fail to rescue cardiac dysfunction. ( A ) Brief schedule of in vivo experiment. C57BL/6J mice were treated with ferrostatin-1 (Fer-1) or liproxstatin-1 (Lip-1) 24 h before doxorubicin injection and were dosed every 24 h. A single dose of doxorubicin was administered intraperitoneally once on day 1. Experimental groups: Vehicle, DOX (20 mg/kg, i.p.), DOX + Fer-1 (2 mg/kg, i.p.), and DOX + Lip-1 (10 mg/kg, i.p.) ( B ) The survival graph of mice from different groups was shown by Kaplan–Meier survival analysis. ( C ) Three days after intraperitoneal injection of doxorubicin, the mouse cardiac function was analyzed with echocardiography. The echocardiography data showed decreased fractional shortening and ejection fraction in mice treated with doxorubicin and Fer-1 or Lip-1. Survival rate, n = 5 per group; ECG, n = 5 per group. ( D ) Bar graph representation of the heart weight to body weight ratio of mice. ( E ) 3,3’-Diaminobenzidine immunohistochemical staining for 4-hydroxynonenal (4-HNE) in the mouse heart tissue; scale bars, 200 µm (left panel). Quantification of 4-HNE-specific 3,3’-Diaminobenzidine staining (right panel). ( F ) Bar graph representation of the N-terminal pro B-type natriuretic peptide (NT-proBNP) of mice. ( G ) Masson’s trichrome and Sirius red staining of fibrosis in the mouse heart (left panel) and quantification (right panel). ( H ) Western blot of ferroptosis cell death markers in mouse heart tissues treated with doxorubicin and Fer-1 or Lip-1. heart weight to body weight, n = 3 per group; 4-HNE, n = 3 per group; NT-proBNP, n = 7 per group; Masson’s trichrome and Sirius red, n = 3 per group; Western blots, n = 3 per group. Data are presented as mean ± S.D., where n represents the number of individual mice per group. Statistical significance was determined by one-way ANOVA followed by Sidak’s multiple comparison test for panels ( C , F ), and the Kruskal–Wallis test was used for panels ( D , E , G ), ns, no significance, * p < 0.05, ** p < 0.01, *** p < 0.005, **** p < 0.001.

Journal: Antioxidants

Article Title: Limitations of Ferroptosis Inhibitors on the Doxorubicin-Induced Cardiotoxicity

doi: 10.3390/antiox15010027

Figure Lengend Snippet: Ferroptosis inhibitors fail to rescue cardiac dysfunction. ( A ) Brief schedule of in vivo experiment. C57BL/6J mice were treated with ferrostatin-1 (Fer-1) or liproxstatin-1 (Lip-1) 24 h before doxorubicin injection and were dosed every 24 h. A single dose of doxorubicin was administered intraperitoneally once on day 1. Experimental groups: Vehicle, DOX (20 mg/kg, i.p.), DOX + Fer-1 (2 mg/kg, i.p.), and DOX + Lip-1 (10 mg/kg, i.p.) ( B ) The survival graph of mice from different groups was shown by Kaplan–Meier survival analysis. ( C ) Three days after intraperitoneal injection of doxorubicin, the mouse cardiac function was analyzed with echocardiography. The echocardiography data showed decreased fractional shortening and ejection fraction in mice treated with doxorubicin and Fer-1 or Lip-1. Survival rate, n = 5 per group; ECG, n = 5 per group. ( D ) Bar graph representation of the heart weight to body weight ratio of mice. ( E ) 3,3’-Diaminobenzidine immunohistochemical staining for 4-hydroxynonenal (4-HNE) in the mouse heart tissue; scale bars, 200 µm (left panel). Quantification of 4-HNE-specific 3,3’-Diaminobenzidine staining (right panel). ( F ) Bar graph representation of the N-terminal pro B-type natriuretic peptide (NT-proBNP) of mice. ( G ) Masson’s trichrome and Sirius red staining of fibrosis in the mouse heart (left panel) and quantification (right panel). ( H ) Western blot of ferroptosis cell death markers in mouse heart tissues treated with doxorubicin and Fer-1 or Lip-1. heart weight to body weight, n = 3 per group; 4-HNE, n = 3 per group; NT-proBNP, n = 7 per group; Masson’s trichrome and Sirius red, n = 3 per group; Western blots, n = 3 per group. Data are presented as mean ± S.D., where n represents the number of individual mice per group. Statistical significance was determined by one-way ANOVA followed by Sidak’s multiple comparison test for panels ( C , F ), and the Kruskal–Wallis test was used for panels ( D , E , G ), ns, no significance, * p < 0.05, ** p < 0.01, *** p < 0.005, **** p < 0.001.

Article Snippet: ECG recordings were conducted for 22 days, with each mouse housed individually in a cage equipped with a receiver (RPC-1, Data Sciences International).

Techniques: In Vivo, Injection, Immunohistochemical staining, Staining, Western Blot, Comparison

Ferroptosis inhibitors do not alleviate doxorubicin-induced arrhythmic changes in mice. ( A ) Electrocardiogram (ECG) traces recorded on day 1 after DOX administration with or without ferroptosis inhibitors, showing various arrhythmic events, including tachyarrhythmia, frequent premature ventricular contractions, irregular rhythm, and cardiac arrest. Red arrows indicate representative arrhythmic events, including premature ventricular contractions and irregular R−R intervals. ( B ) ECG traces recorded on day 21, demonstrating the progression of arrhythmic changes, including atrioventricular (AV) block and bradycardia with AV block, indicated by red arrows. n = 4 per group. Data are presented as mean ± S.D., where n represents the number of individual mice per group. Statistical significance was determined by one-way ANOVA followed by Sidak’s multiple comparison test.

Journal: Antioxidants

Article Title: Limitations of Ferroptosis Inhibitors on the Doxorubicin-Induced Cardiotoxicity

doi: 10.3390/antiox15010027

Figure Lengend Snippet: Ferroptosis inhibitors do not alleviate doxorubicin-induced arrhythmic changes in mice. ( A ) Electrocardiogram (ECG) traces recorded on day 1 after DOX administration with or without ferroptosis inhibitors, showing various arrhythmic events, including tachyarrhythmia, frequent premature ventricular contractions, irregular rhythm, and cardiac arrest. Red arrows indicate representative arrhythmic events, including premature ventricular contractions and irregular R−R intervals. ( B ) ECG traces recorded on day 21, demonstrating the progression of arrhythmic changes, including atrioventricular (AV) block and bradycardia with AV block, indicated by red arrows. n = 4 per group. Data are presented as mean ± S.D., where n represents the number of individual mice per group. Statistical significance was determined by one-way ANOVA followed by Sidak’s multiple comparison test.

Article Snippet: ECG recordings were conducted for 22 days, with each mouse housed individually in a cage equipped with a receiver (RPC-1, Data Sciences International).

Techniques: Blocking Assay, Comparison

ECG changes and cardiac enzymes changes in the different studied groups: a: significance from the control group by LSD at p ≤ 0.05. b: Significance from the hypothyroid group by LSD at p ≤ 0.05. c: Significance from the L-thyroxine-treated hypothyroid group by LSD at p ≤ 0.05. d: Significance from the sesame oil-treated hypothyroid group by LSD at p ≤ 0.05.

Journal: Frontiers in Physiology

Article Title: A comparative study on L-thyroxine treatment and sesame oil supplementation in experimentally induced hypothyroidism in rats

doi: 10.3389/fphys.2025.1606528

Figure Lengend Snippet: ECG changes and cardiac enzymes changes in the different studied groups: a: significance from the control group by LSD at p ≤ 0.05. b: Significance from the hypothyroid group by LSD at p ≤ 0.05. c: Significance from the L-thyroxine-treated hypothyroid group by LSD at p ≤ 0.05. d: Significance from the sesame oil-treated hypothyroid group by LSD at p ≤ 0.05.

Article Snippet: When the stage of surgical anesthesia was reached, an ECG recording was performed using the ECG recorder Cardimax FX-2111 (Fukuda Denshi Co., Ltd., Japan).

Techniques: Control